🇺🇸 FDA
Pipeline program

nexiguran ziclumeran

ITL-2001-CL-311

Phase 3 mab active

Quick answer

nexiguran ziclumeran for Neuromuscular Disease is a Phase 3 program (mab) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Regeneron UK Limited
Indication
Neuromuscular Disease
Phase
Phase 3
Modality
mab
Status
active

Clinical trials